Avalo Therapeutics
Rockville
About Avalo Therapeutics
Avalo Therapeutics is a clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize highly targeted therapeutics in areas of significant unmet clinical need.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $231.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2024)
- Ticker: nasdaq:AVTX
- Website: avalotx.com
- Phone: +1 610-254-4205
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/avalo-therapeutics-130351 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.